129 related articles for article (PubMed ID: 6226452)
1. Mechanism of cytotoxic activity of 5'-deoxy-5-fluorouridine.
Armstrong RD; Connolly KM; Kaplan AM; Cadman E
Cancer Chemother Pharmacol; 1983; 11(2):102-5. PubMed ID: 6226452
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
Armstrong RD; Diasio RB
Cancer Res; 1980 Sep; 40(9):3333-8. PubMed ID: 6253060
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
Armstrong RD; Diasio RB
Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
[TBL] [Abstract][Full Text] [Related]
4. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
Takimoto CH; Cadman EC; Armstrong RD
Mol Pharmacol; 1986 Jun; 29(6):637-42. PubMed ID: 2940459
[TBL] [Abstract][Full Text] [Related]
5. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
Takimoto CH; Tan YY; Cadman EC; Armstrong RD
Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
[TBL] [Abstract][Full Text] [Related]
6. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activity of 5'-deoxy-5-fluorouridine in cultured human tumors.
Armstrong RD; Gesmonde J; Wu T; Cadman E
Cancer Treat Rep; 1983 Jun; 67(6):541-5. PubMed ID: 6222789
[TBL] [Abstract][Full Text] [Related]
8. 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.
Armstrong RD; Cadman E
Cancer Res; 1983 Jun; 43(6):2525-8. PubMed ID: 6221792
[TBL] [Abstract][Full Text] [Related]
9. Decreased immunosuppression associated with antitumor activity of 5-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine.
Connolly KM; Diasio RB; Armstrong RD; Kaplan AM
Cancer Res; 1983 Jun; 43(6):2529-35. PubMed ID: 6221793
[TBL] [Abstract][Full Text] [Related]
10. The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells.
Temmink OH; de Bruin M; Laan AC; Turksma AW; Cricca S; Masterson AJ; Noordhuis P; Peters GJ
Int J Biochem Cell Biol; 2006; 38(10):1759-65. PubMed ID: 16798057
[TBL] [Abstract][Full Text] [Related]
11. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.
Eda H; Fujimoto K; Watanabe S; Ishikawa T; Ohiwa T; Tatsuno K; Tanaka Y; Ishitsuka H
Jpn J Cancer Res; 1993 Mar; 84(3):341-7. PubMed ID: 8486533
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridine.
Miwa M; Ishikawa T; Eda H; Ryu M; Fujimoto K; Ninomiya Y; Umeda I; Yokose K; Ishitsuka H
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):998-1003. PubMed ID: 2143107
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil.
Ajmera S; Bapat AR; Stephanian E; Danenberg PV
J Med Chem; 1988 Jun; 31(6):1094-8. PubMed ID: 2967375
[TBL] [Abstract][Full Text] [Related]
14. Interactions of interferon-alpha 2a with 5'-deoxy-5-fluorouridine in colorectal cancer cells in vitro.
Tevaearai HT; Laurent PL; Suardet L; Eliason JF; Givel JC; Odartchenko N
Eur J Cancer; 1992; 28(2-3):368-72. PubMed ID: 1534247
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancer.
de Bruijn EA; van Oosterom AT; Tjaden UR; Reeuwijk HJ; Pinedo HM
Cancer Res; 1985 Nov; 45(11 Pt 2):5931-5. PubMed ID: 2932219
[TBL] [Abstract][Full Text] [Related]
16. Role of administration route in the therapeutic efficacy of doxifluridine.
Trave F; Canobbio L; Au JL; Rustum YM
J Natl Cancer Inst; 1987 Mar; 78(3):527-32. PubMed ID: 2950266
[TBL] [Abstract][Full Text] [Related]
17. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
[TBL] [Abstract][Full Text] [Related]
19. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.
Van Der Heyden SA; Highley MS; De Bruijn EA; Tjaden UR; Reeuwijk HJ; Van Slooten H; Van Oosterom AT; Maes RA
Br J Clin Pharmacol; 1999 Apr; 47(4):351-6. PubMed ID: 10233196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
